IN2014MN02675A - - Google Patents

Info

Publication number
IN2014MN02675A
IN2014MN02675A IN2675MUN2014A IN2014MN02675A IN 2014MN02675 A IN2014MN02675 A IN 2014MN02675A IN 2675MUN2014 A IN2675MUN2014 A IN 2675MUN2014A IN 2014MN02675 A IN2014MN02675 A IN 2014MN02675A
Authority
IN
India
Application number
Inventor
Aldecoa Eduardo Anitua
Original Assignee
Biotechnology Inst I Mas D Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49111229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014MN02675(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotechnology Inst I Mas D Sl filed Critical Biotechnology Inst I Mas D Sl
Publication of IN2014MN02675A publication Critical patent/IN2014MN02675A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IN2675MUN2014 2012-08-09 2014-12-31 IN2014MN02675A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201200810A ES2442242B1 (en) 2012-08-09 2012-08-09 Composition with growth factors intended for intranasal treatment of a neurodegenerative disease or other pathology of the central nervous system, and its manufacturing method.
PCT/ES2013/000176 WO2014023860A1 (en) 2012-08-09 2013-07-19 Compositions comprising plasma growth factors for use in the treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
IN2014MN02675A true IN2014MN02675A (en) 2015-08-28

Family

ID=49111229

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2675MUN2014 IN2014MN02675A (en) 2012-08-09 2014-12-31

Country Status (17)

Country Link
US (2) US20140044795A1 (en)
EP (1) EP2883569B1 (en)
JP (1) JP6339568B2 (en)
KR (1) KR102149162B1 (en)
CN (1) CN104519961A (en)
AR (1) AR092086A1 (en)
BR (1) BR112015002760A2 (en)
CA (1) CA2881075A1 (en)
CL (1) CL2014003510A1 (en)
CO (1) CO7170177A2 (en)
ES (2) ES2442242B1 (en)
IN (1) IN2014MN02675A (en)
MX (1) MX357828B (en)
PE (1) PE20150616A1 (en)
RU (1) RU2696497C2 (en)
TW (1) TWI649084B (en)
WO (1) WO2014023860A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2016003282A1 (en) 2016-12-21 2017-08-18 Univ Chile Aav / igf2 virus, method of genetic treatment and its use in diseases related to protein misfolding such as huntington's disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531489A (en) * 1998-12-09 2002-09-24 カイロン コーポレイション Administration of neurotrophic drugs to the central nervous system
AR022333A1 (en) 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo OSEO FABRIC REGENERATOR
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
ES2221770B2 (en) 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa METHOD OF PREPARATION OF A COMPOUND FOR THE REGENERATION OF FABRICS.
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
US20090317377A1 (en) * 2005-08-26 2009-12-24 Yeomans David C Therapy procedure for drug delivery for trigeminal pain
CA2687505C (en) * 2007-06-08 2013-10-08 Healthpartners Research Foundation Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
ES2333498B1 (en) * 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. METHOD AND COMPOUND FOR THE TREATMENT OF ARTICULAR DISEASES OR PAINTS OR FOR THE TREATMENT OF SKIN FOR AESTHETIC OR OTHER PURPOSES, AND THE METHOD OF PREPARATION OF THE COMPOUND.
JP2010539123A (en) * 2007-09-14 2010-12-16 エスシーアイエル テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング Neuroendocrine factors for the treatment of degenerative diseases
ES2780057T3 (en) 2009-05-14 2020-08-21 Biotechnology Institute I Mas D Sl Method for the preparation of at least one compound from blood, and sampling devices to be used in the execution of said method
KR101114712B1 (en) * 2009-10-23 2012-02-29 세원셀론텍(주) A Platelet rich plasma using regeneration constituent manufacturing method thereof
ES2369945B1 (en) 2011-07-29 2012-10-15 Eduardo Anitua Aldecoa PROCEDURE FOR OBTAINING A COMPOSITION CONTAINING GROWTH FACTORS FROM A BLOOD COMPOUND, AND COMPOSITION OBTAINABLE BY SUCH PROCEDURE.

Also Published As

Publication number Publication date
AR092086A1 (en) 2015-03-25
KR102149162B1 (en) 2020-08-31
WO2014023860A1 (en) 2014-02-13
ES2442242A1 (en) 2014-02-10
MX2015001677A (en) 2015-04-10
CA2881075A1 (en) 2014-02-13
US20160184360A1 (en) 2016-06-30
JP6339568B2 (en) 2018-06-06
CL2014003510A1 (en) 2015-05-04
PE20150616A1 (en) 2015-05-25
ES2662385T3 (en) 2018-04-06
CO7170177A2 (en) 2015-01-28
MX357828B (en) 2018-07-25
BR112015002760A2 (en) 2020-04-22
EP2883569B1 (en) 2017-12-20
TWI649084B (en) 2019-02-01
ES2442242B1 (en) 2014-11-25
KR20150040860A (en) 2015-04-15
RU2696497C2 (en) 2019-08-02
TW201408310A (en) 2014-03-01
RU2015104076A (en) 2016-09-27
US20140044795A1 (en) 2014-02-13
EP2883569A1 (en) 2015-06-17
JP2015524464A (en) 2015-08-24
CN104519961A (en) 2015-04-15

Similar Documents

Publication Publication Date Title
BR112015012238A2 (en)
BR112014017635A2 (en)
BR112014018171A2 (en)
BR112014017592A2 (en)
BR112014017659A2 (en)
BR112014017646A2 (en)
AR092201A1 (en)
BR112014017638A2 (en)
BR112014017607A2 (en)
BR112014024270A2 (en)
BR112013027865A2 (en)
BR112014017644A2 (en)
BR112014017588A2 (en)
BR112014017647A2 (en)
BR112014013184A8 (en)
BR112014017652A2 (en)
BR112014017641A2 (en)
BR112015014744A2 (en)
BR112014017636A2 (en)
BR112014017667A2 (en)
BR112014017671A2 (en)
BR112014018159A2 (en)
BR112014017948A2 (en)
BR112014017596A2 (en)
BR112014019040A2 (en)